Bottom line
TMED vs JEHSX: the short answer
TMED (T. Rowe Price Health Care ETF) and JEHSX (Health Sciences Trust) share a meaningful slice of their top holdings — about 46% by weight.
TMED is cheaper at 0.44% vs 1.04% — a difference of $60 a year per $10,000 invested.
Updated Nov 19, 2026
TMED vs JEHSX side by side
| TMED | JEHSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | T. Rowe Price | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.44% | 1.04% |
| Annual cost per $10k | $44 | $104 |
| 10-yr cost on $10k (prospectus) | $555 | $1,282 |
| Max front load | None | — |
| 12b-1 fee | — | 0.05% |
| 1-yr return | — | +19.5% |
| 5-yr return (annualized) | — | +4.2% |
| 10-yr return (annualized) | — | +8.7% |
| Best quarter | — | +23.6% |
| Worst quarter | — | −16.1% |
| Net assets (fund) | $23.0M | $251.3M |
| Number of holdings | 102 | 173 |
| Portfolio turnover | 44% | 68% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
7 of TMED's top 25 holdings also appear in JEHSX's top 25.
| Holding | TMED | JEHSX |
|---|---|---|
| Eli Lilly & Co | 16.71% | 14.30% |
| Unitedhealth Group Inc | 6.52% | 5.95% |
| Gilead Sciences Inc | 4.44% | 2.95% |
| Thermo Fisher Scientific Inc | 4.11% | 2.67% |
| Danaher Corp | 2.96% | 1.51% |
| Intuitive Surgical Inc | 2.43% | 1.98% |
| Stryker Corp | 2.22% | 1.87% |
Source: SEC Form N-PORT
TMED top 10
- Eli Lilly & Co — 16.71%
- Unitedhealth Group Inc — 6.52%
- Gilead Sciences Inc — 4.44%
- Thermo Fisher Scientific Inc — 4.11%
- Danaher Corp — 2.96%
- Cencora Inc — 2.75%
- Agilent Technologies Inc — 2.61%
- Alnylam Pharmaceuticals Inc — 2.60%
- Intuitive Surgical Inc — 2.43%
- Insulet Corp — 2.38%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between TMED and JEHSX?
TMED (T. Rowe Price Health Care ETF) and JEHSX (Health Sciences Trust) share a meaningful slice of their top holdings — about 46% by weight. TMED is cheaper at 0.44% vs 1.04% — a difference of $60 a year per $10,000 invested.
Which is cheaper, TMED or JEHSX?
TMED has the lower expense ratio (0.44%).
Should I own both TMED and JEHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.